Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

President Donald Trump's executive order mandates drugmakers to lower prices to match those in affluent nations, threatening ...

Eli Lilly is pumping iron in the GLP-1 prescription ring, gaining muscle with a 52.4% market share and a beefy $1,100 target.

President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

By Steve Holland, Michael Erman and Patrick Wingrove WASHINGTON (Reuters) - U.S. President Donald Trump signed a ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 13, 2025 /EINPresswire.com/ -- The market for Huntington's disease has seen a sharp increase in recent years. It is estimated to grow from $0.47 billion in ...

US President Donald Trump said Monday he would slash drug prices so they match those abroad, accusing Europe in particular of ...

US President Donald Trump signed an executive order requiring drugmakers to lower prices, aligning with international rates.

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their ...